DrugPatentWatch Database Preview
Patent: 5,844,099
» See Plans and Pricing
Summary for Patent: 5,844,099
| Title: | Cytokine antagonists |
| Abstract: | Heteromeric proteins comprising a soluble .alpha. specificity determining cytokine receptor component and the extracellular domain of a .beta. receptor component function as cytokine antagonists. |
| Inventor(s): | Stahl; Neil (Carmel, NY), Economides; Aris (Dobbs Ferry, NY), Yancopoulos; George D. (Yorktown Heights, NY) |
| Assignee: | Regeneron Pharmaceuticals, Inc. (Tarrytown, NY) |
| Application Number: | 08/563,105 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,844,099
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals | ARCALYST | rilonacept | VIAL; SINGLE-USE | 125249 | 001 | 2008-02-27 | Start Trial | Regeneron Pharmaceuticals, Inc. (Tarrytown, NY) | 2013-10-20 | RX | Orphan | company |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 5,844,099
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 948242 | Start Trial |
| World Intellectual Property Organization (WIPO) | 9511303 | Start Trial |
| United States of America | 5470952 | Start Trial |
| Portugal | 726954 | Start Trial |
| Japan | 3961562 | Start Trial |
| Japan | H09504030 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
